Tesla (TSLA) › Analysis

Tesla (TSLA) stock analysis, May 15, 2026: TSLA kills Model S and X for robots — can $400 support hold?

Published May 15, 2026 · TSLA chart, levels and live analysis

Key Updates

Tesla shares declined 2.76% to $425.63 since the May 13 report, reversing the prior rally and falling back below the psychologically important $430 level. This pullback follows three consecutive positive reports and reflects growing investor concern over the company's strategic pivot from traditional automotive manufacturing to AI and robotics, as evidenced by new reporting that Tesla discontinued the Model S and Model X lines to allocate factory capacity for humanoid robot production. The stock now trades 6.4% above Morningstar's $400 fair value estimate but remains 5.36% below year-to-date levels, suggesting the recent recovery rally may be losing momentum amid mounting questions about near-term profitability given the company's tripling of capital expenditures to over $25 billion annually.

Current Trend

Tesla shares exhibit a conflicting technical picture with positive momentum over the 1-month (+8.59%) and 6-month (+5.26%) periods, but negative year-to-date performance (-5.36%) and recent weakness over the past day (-3.99%) and five days (-0.63%). The stock has established a new trading range between $400 (Morningstar fair value and previous resistance) and $440, with the current price of $425.63 positioned in the middle of this channel. The recent pullback from the May 13 high of $437.72 suggests profit-taking after the 24.79% rally from April lows, though the stock has held above the critical $400 support level that previously acted as resistance. The year-to-date decline of 5.36% contrasts sharply with broader market performance, indicating Tesla-specific headwinds continue to weigh on investor sentiment despite the recent recovery attempt.

Investment Thesis

The investment thesis for Tesla has fundamentally shifted from a pure-play electric vehicle manufacturer to a speculative bet on artificial intelligence, autonomous driving, and robotics. The company's stock valuation of over 180 times expected earnings reflects investor willingness to discount significant near-term automotive challenges—including two consecutive years of declining EV sales, loss of market leadership to BYD, and 27% European sales decline—in favor of potential long-term value creation from Full Self-Driving technology, robotaxis, and Optimus humanoid robots. Tesla maintains structural advantages including the world's largest EV charging network, strong brand recognition, manufacturing cost leadership, and robust financial health with $44 billion in cash against $8.2 billion in debt. However, the thesis carries Very High Uncertainty given the company's strategic decision to discontinue profitable vehicle lines (Model S and X), project negative free cash flow for the remainder of 2026, and triple capital expenditures to over $25 billion annually while facing intensifying competition from lower-cost Chinese manufacturers and weakening demand in key markets.

Thesis Status

The investment thesis status has deteriorated since the previous report as new information reveals the extent of Tesla's operational transformation and near-term financial trade-offs. The discontinuation of Model S and Model X production to allocate capacity for Optimus robot manufacturing represents a more aggressive pivot than previously understood, eliminating two established revenue streams before replacement products achieve commercial viability. Management's guidance for negative free cash flow through year-end 2026 and capital expenditures exceeding $25 billion (triple 2025 levels) materially increases execution risk and extends the timeline for positive returns on the AI and robotics investments. While Q1 2026 results showed 16% revenue growth and 17% profit growth, operating margins compressed to 4.2% for the second consecutive quarter as operating expenses surged 37%, confirming that the strategic transformation is pressuring near-term profitability. The mixed robotaxi rollout—fully autonomous in three Texas cities but requiring human drivers in San Francisco due to regulatory constraints—highlights the uncertain path to commercialization. Morningstar's maintenance of its $400 fair value estimate and 3-star rating suggests the current price of $425.63 offers limited margin of safety given these elevated execution risks.

Key Drivers

Tesla's strategic transformation from automotive manufacturer to AI and robotics company represents the dominant driver, with the company establishing Terafab (a joint chipmaking venture with SpaceX), planning construction of an Optimus robot factory with initial capacity of 1 million units annually in Fremont and eventual 10 million unit capacity at Gigafactory Texas, and discontinuing Model S and Model X lines to reallocate production capacity (The Verge, Axios). The automotive business faces significant headwinds with global deliveries declining 9% to 1.64 million vehicles in 2025, European sales dropping 27%, and the company losing its position as the world's largest EV maker to BYD amid aggressive pricing pressure from Chinese competitors including BYD, XPeng, and Xiaomi (Forbes). Capital allocation represents a critical near-term concern with management projecting negative free cash flow for the remainder of 2026 as capital expenditures triple to over $25 billion annually to fund AI infrastructure, robotaxi expansion, and humanoid robot production (Morningstar). Speculation regarding a potential merger with SpaceX—expected to go public at a valuation near $2 trillion—has emerged as a supporting factor following CEO comments about operational complexities from the companies being separate entities, particularly regarding semiconductor fabrication projects (CNBC). Regulatory progress includes securing approval for Full Self-Driving Supervised in the Netherlands and expanding robotaxi operations to Dallas and Houston, though the service still requires human drivers in San Francisco Bay Area markets (The Verge).

Technical Analysis

Tesla shares at $425.63 are consolidating within a $400-$440 range established over the past month following a 24.79% rally from April lows. The current price represents a 2.76% decline from the May 13 high of $437.72, suggesting near-term momentum has stalled as the stock encounters resistance in the $430-$440 zone. The $400 level has transitioned from resistance to support, coinciding with Morningstar's fair value estimate and representing a critical technical floor that has held on multiple tests since early May. The stock's 6.4% premium to the $400 fair value provides limited upside cushion given Morningstar's 3-star rating and recommendation for a larger margin of safety. Year-to-date performance of -5.36% establishes overhead resistance and suggests sellers remain active on rallies toward break-even levels. The 1-month gain of 8.59% and 6-month gain of 5.26% indicate intermediate-term trend improvement, but recent daily weakness (-3.99% over 1 day, -0.63% over 5 days) signals potential exhaustion of the recovery rally. Volume patterns and momentum indicators suggest the stock requires a catalyst to break above the $440 resistance level or risks retesting the $400 support zone.

Bull Case

Bear Case

Get a message when the TSLA picture changes — the agent team watches the levels and the news for you.Create a free account

More TSLA analyses